NDC 24075-0411

Conjupri

Levamlodipine

Conjupri is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Cspc Ouyi Pharmaceutical Co. Ltd. The primary component is Levamlodipine Maleate.

Product ID24075-0411_1e8312e8-9f2f-4463-8835-70d7fe6c9b90
NDC24075-0411
Product TypeHuman Prescription Drug
Proprietary NameConjupri
Generic NameLevamlodipine
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2021-10-08
Marketing CategoryNDA / NDA
Application NumberNDA212895
Labeler NameCSPC Ouyi Pharmaceutical Co. Ltd
Substance NameLEVAMLODIPINE MALEATE
Active Ingredient Strength3 mg/2.5mg
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 24075-0411-3

2.5 mg in 1 BOTTLE (24075-0411-3)
Marketing Start Date2021-10-08
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Conjupri" or generic name "Levamlodipine"

NDCBrand NameGeneric Name
24075-0410Conjuprilevamlodipine
24075-0411Conjuprilevamlodipine
24075-0412Conjuprilevamlodipine
24075-0413Conjuprilevamlodipine
66992-425Conjuprilevamlodipine
66992-430Conjuprilevamlodipine
69101-512Conjuprilevamlodipine maleate
69101-525Conjuprilevamlodipine maleate
69101-550Conjuprilevamlodipine maleate
42195-425Levamlodipinelevamlodipine
42195-450Levamlodipinelevamlodipine

Trademark Results [Conjupri]

Mark Image

Registration | Serial
Company
Trademark
Application Date
CONJUPRI
CONJUPRI
88716966 not registered Live/Pending
Conjupro Biotherapeutics Inc.
2019-12-05
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.